AT

Andrew Tan

North America, California, United States, Atherton

Description

Andrew Tan

Investor Profile

Andrew Tan has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Artificial Intelligence (AI), Biotechnology, Health Care.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Biotechnology
  • Health Care
  • Life Science
  • Precision Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Andrew Tan frequently co-invest with?

Prosperity7 Ventures
Asia, Ash Sharqiyah, Saudi Arabia, Dhahran
Co-Investments: 1
Walden Catalyst
North America, California, United States, San Francisco
Co-Investments: 1
Trium
Africa, Lagos, Nigeria, Lekki
Co-Investments: 1
Wilson Sonsini Goodrich & Rosati
North America, California, United States, Palo Alto
Co-Investments: 1
EDBI
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
AIspace Ventures
North America, California, United States, Los Altos Hills
Co-Investments: 1

Which angels does Andrew Tan often collaborate with?

RK
North America, California, United States, San Francisco
Shared Deals: 1
NC
North America, California, United States, Menlo Park
Shared Deals: 1

What are some of recent deals done by Andrew Tan?

Artera

Los Altos, California, United States

Artera develops multimodal artificial intelligence-based predictive and prognostic cancer tests to customize treatments for cancer patients.

Artificial Intelligence (AI)BiotechnologyHealth CareLife SciencePrecision Medicine
Series UnknownFeb 1, 2024
Amount Raised: $20,000,000